Trial NCT04845035

View at ClinicalTrials.gov 
Org. Study IDs: UMCC 2018.144
Secondary IDs: HUM00171952

Last trial update was posted on 2024-02-22

MeSH Interventions

Cytarabine Dasatinib Methotrexate Ponatinib

MeSH Conditions

Leukemia Leukemia, Lymphoid Philadelphia Chromosome Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions

Acute Lymphoblastic Leukemia

Stopping Reasons

The PI plans to revise the study design in a new protocol

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID